医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ZS Announces ZAIDYNTM Platform to Accelerate Digital Journeys in Life Sciences

2021年09月14日 PM10:47
このエントリーをはてなブックマークに追加


 

EVANSTON, Ill.

Global professional services firm ZS has announced the launch of ZAIDYN by ZS—a platform for life sciences companies of all sizes to digitally transform and scale customer engagement, field performance, analytics and clinical capabilities.

ZAIDYN delivers through intelligent business applications, the power of a self-learning network and a ready-to-use library of algorithms. The platform integrates with existing technology environments via an open, modular, cloud-based architecture featuring business-ready connectors to third-party data sources, business apps and enterprise systems.

“Today, we are announcing ZAIDYN, expanding on more than 35 years of software expertise from our JAVELIN, VERSO and REVO product lines,” said Sanjay Joshi, managing principal and platform lead for ZS. “Built on a common foundation, ZAIDYN allows clients to adopt products, applications, algorithms and data assets in a modular way. It connects well with IT systems, resulting in easier integration, lower cost of operations and global scale. As a life sciences AI platform, ZAIDYN gets smarter over time and increases in value for our clients.”

With ZAIDYN, leaders in business, analytics and technology have more paths to improve the processes that deliver business and patient value. They can:

  • Drive faster and better decision-making with more insightful, dynamic reporting and analytics
  • Create personalized experiences to deepen customer relationships
  • Deploy and guide field teams for more effective support of healthcare markets
  • Spark digital learning for greater speed to value in business model transformation efforts
  • Ready company infrastructure for the future of digital clinical trial design and monitoring

More than 130 companies already use ZS’s products to drive business decisions, and over 100,000 pharmaceutical field reps worldwide use ZS insights to engage their customers.

“ZAIDYN will help our clients navigate the large-scale, disruptive changes we see happening across our industry,” said Pratap Khedkar, CEO of ZS. “Digital platforms for life sciences can help us deliver the experiences customers expect and businesses want. It’s all about using insights from data more effectively to drive better patient outcomes.”

“We’re changing how we support our commercial businesses with the help of ZS and the ZAIDYN platform,” said Andreas Henrich, corporate vice president of IT enterprise data services at Boehringer Ingelheim. “First, we updated and shifted our data and analytics solutions to a global cloud-based solution. Then, we plugged in the customer engagement capabilities we wanted on top. The platform integrates with our existing systems and can handle a lot more down the road as we deliver new customer and patient experiences.”

Learn more and register for upcoming webinars at zs.com/zaidyn.

About ZS

ZS is a professional services firm that works side by side with companies to help develop and deliver products that drive customer value and company results. We leverage our deep industry expertise, leading-edge analytics, technology and strategy to create solutions that work in the real world. With more than 37 years of experience and 10,000-plus ZSers in more than 28 offices worldwide, we are passionately committed to helping companies and their customers thrive. To learn more, visit www.zs.com or follow us on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210914005297/en/

CONTACT

Quintin Maidment

The Bliss Group

zs@theblissgrp.com

+1 212 600 2584

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表